our doctors

Meet Our Experienced Team of Medical Professionals

Search for Doctors

For Emergency Call: 044 – 400 12345

Dr. R. Radhakrishnan

Dr. R. Radhakrishnan

Senior Consultant & Hocs

Education
M.B.B.S, M.S., MCh( Vascular )., MRCS, Dip.N.B

Area(s) of Specialization
Vascular surgeron

Experience
17 years after M.Ch (Vascular surgery)

Consultation days:
Monday to Saturday
Consultation Time:
8.00 am to 3.00 pm
For Appointment, Call:
044 – 45928505 EXT: 599

Fellowships / Memberships:

1 year in Queen Elizabeth Hospital, Birmingham UK

Publications

  • “Composite sequential bypass using profunda vein hitchhike”. Journal of Vascular Surgery
  • “Iatrogenic arteriovenous fistula unveiling aberrant left renal vein”- Journal of Vascular Surgery
  • “An unusual variant of Klippel – Trenaunay syndrome”- International Surgery Journal
  • “A RARE CASE OF BASILIC VEIN ANEURYSM”.- Indian Journal Of Medical Case
  • “Long – Term Follow – Up of Autologous Bone Marrow Cell Therapy: A Randomized Controlled Double – Blind Study for No – Option CLI” - Journal of Vascular Surgery
  • “Early results and lessons learned from a multicentre, randomized double – blind trial of bone marrow aspirate concentrate in critical limb ischemia” - Journal of Vascular Surgery
  • “Safety and Efficiacy of Rapid Autologous Bone Marrow Aspirate Concentrate for the Treatment of Critical Limb Ischemia in Buerger’s Disease” - Journal of Vascular Surgery

Research

  • “Safety and Efficacy of Dexadine ( cadexomer iodine) in the treatment of chronic wounds”
  • “Feasibility Study of the Safety and Activity of Autologous Bone Marrow Aspirate Concentrate (BMAC) For the Treatment of Non Reconstructable Critical Limb Ischemia Due To Peripheral Arterial Occlusive Disease”
  • “A Phase II, Randomized, Prospective, Double blind, Parallel group, Multi-Center Study to Determine the Safety and Efficacy of GRANEXIN GEL in the Treatment of Venous Leg Ulcer”.
  • A Non-Randomized, Open Label, Multicentric, Dose Ranging, Phase II Study Assessing the Efficacy and Safety of Intramuscular Administration of Stempeucel- CLITM (Ex Vivo Cultured Adult Bone Marrow Derived Allogeneic Mesenchymal Stem Cells) in Patients with Critical Limb Ischemia due to Buerger’s Disease”.